Abstract:Rabies virus (RABV) causes fatal neurological encephalitis and results in approximately 6000 human death cases worldwide every year. The large (L) protein of RABV, possessing conserved domains, is considered as the target for detection. In this study, three monoclonal antibodies (mAbs), designated as 3F3, 3A6 and L-C, against L protein were generated by using the recombinant truncated L protein (aa 1431-1754) and the epitopes were also identified using a series of overlapping truncated polypeptides for testing the reactivity of mAbs with different RABV strains. The (EIFSIP1484)-E-1479, (1659)RALSK(1663) and (VFNSL1728)-V-1724 were identified as the minimal linear epitopes recognized by mAbs 3F3, 3A6 and L-C, respectively. Amino acid alignment showed epitope (VFNSL1728)-V-1724 recognized by mAb L-C is completely conserved among RABV strains, indicating that mAb L-C could be used to detect all of the RABV strains. Epitope (EIFSIP1484)-E-1479 is highly conserved among RABV strains except for a P1484S substitution in a China I sub-lineage strain of Asian lineage, which eliminated the reactivity of the epitope with mAb 3F3. However, the epitope (1659)RALSK(1663) was only completely conserved in the Africa-2 and Indian lineages, and a single A1660T substitution, mainly appeared in strains of the China I belonging to Asian lineage and a Cosmopolitan lineage strain, still retained the reactivity of the epitope with mAb 3A6. While both A1660T and K1663R substitutions in a China I lineage strain, single K1663R/Q substitution in some China II strains of Asian lineage and some Arctic-like lineage strains and R1659Q mutation in a strain of Africa-3 lineage eliminated the reactivity of the epitope with mAb 3A6, suggesting mAb 3A6 could be used for differentiation of variable epitopes of some strains in different lineages. Thus, variability and conservation of the three epitopes of L protein showed the reactive difference of mAbs among RABV strains of different lineages. These results may facilitate future studies in development of detection methods for RABV infection, the structure and function of RABV L protein.

Efficient generation of monoclonal antibodies against major structural proteins of rabies virus with suckling mouse brain antigen.

Generation Of Monoclonal Antibodies Against Variable Epitopes Of The M Protein Of Rabies Virus

Development of Monoclonal Antibodies for Detection of Conserved and Variable Epitopes of Large Protein of Rabies Virus

Development of Human Monoclonal Antibodies With Broad Reactivity for Rabies Postexposure Prophylaxis

Preparation and diagnostic use of a novel recombinant single-chain antibody against rabies virus glycoprotein

Characterization and Potential Diagnostic Application of Monoclonal Antibodies Specific to Rabies Virus

Development of human monoclonal antibodies to rabies.

Characterization of a human–mouse chimeric monoclonal antibody targeting rabies virus glycoprotein

Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein

Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis

Immunogenicity and Antigenicity of the Ectodomain of Rabies Virus Glycoprotein Stably Expressed in HEK293T Cells

Generation and Characterization of the Human Neutralizing Antibody Fragment Fab091 Against Rabies Virus

Development of a novel bispecific antibody GR1801 for rabies

Generation of Genetic Engineering Monoclonal Antibodies Against Prion Protein

Preparation and identification of monoclonal antibody specific to the V region of rabies virus G protein

Characterization of Conformation-Specific Monoclonal Antibodies Against Rabies Virus Nucleoprotein

Efficiency Comparative Approach of Plant-Produced Monoclonal Antibodies against Rabies Virus Infection

Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system

Rapid Production of Monoclonal Antibodies from Single Mouse B Cells Against FMDV

A cocktail of human monoclonal antibodies broadly neutralizes North American rabies virus variants as a promising candidate for rabies post-exposure prophylaxis

Single Domain Antibody Multimers Confer Protection Against Rabies Infection.